AMARIN CORP PLC\UK — Investor Relations & Filings
Amarin Corporation plc is a pharmaceutical company focused on the development and commercialization of therapeutics to improve cardiovascular health. The company's primary mission is to address the persistent cardiovascular risk that remains for many patients despite standard therapies. Its lead product, Vascepa (icosapent ethyl), is a prescription-grade omega-3 fatty acid used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia and to reduce the risk of cardiovascular events in certain high-risk patient groups. Amarin is dedicated to creating a new paradigm in cardiovascular disease management to help prevent heart attacks and strokes for patients worldwide.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-14 | English | |
| 10-Q - AMARIN CORP PLC\UK (0000897448) (Filer) | 2026-04-29 | English | |
| 8-K - AMARIN CORP PLC\UK (0000897448) (Filer) | 2026-04-29 | English | |
| ARS - AMARIN CORP PLC\UK (0000897448) (Filer) | 2026-04-10 | English | |
| DEF 14A - AMARIN CORP PLC\UK (0000897448) (Filer) | 2026-04-10 | English | |
| PRE 14A | 2026-03-30 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46351928 | 8-K | 2026-05-14 | English | ||
| 38525507 | 10-Q - AMARIN CORP PLC\UK (0000897448) (Filer) | 2026-04-29 | English | ||
| 38525362 | 8-K - AMARIN CORP PLC\UK (0000897448) (Filer) | 2026-04-29 | English | ||
| 34033513 | ARS - AMARIN CORP PLC\UK (0000897448) (Filer) | 2026-04-10 | English | ||
| 34030022 | DEF 14A - AMARIN CORP PLC\UK (0000897448) (Filer) | 2026-04-10 | English | ||
| 46294752 | PRE 14A | 2026-03-30 | English | ||
| 33066048 | 8-K - AMARIN CORP PLC\UK (0000897448) (Filer) | 2026-03-27 | English | ||
| 32883539 | 10-K - AMARIN CORP PLC\UK (0000897448) (Filer) | 2026-03-02 | English | ||
| 32883534 | 8-K - AMARIN CORP PLC\UK (0000897448) (Filer) | 2026-02-25 | English | ||
| 25430200 | 4 Filing | 2026-02-03 | English | ||
| 25430173 | 4 Filing | 2026-02-03 | English | ||
| 25430042 | 4 Filing | 2026-02-03 | English | ||
| 25430032 | 4 Filing | 2026-02-03 | English | ||
| 25429960 | 4 Filing | 2026-02-03 | English | ||
| 25429904 | 8-K Filing | 2026-01-08 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
AMARIN CORP PLC\UK via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33214/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33214 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33214 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33214 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33214}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AMARIN CORP PLC\UK (id: 33214)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.